Covishield production stopped in Dec 2021, says Serum Institute's CEO

CEO Adar Poonawalla said Serum Institute of India stopped producing Covishield vaccine from December 2021 and of the total stock available at that time, about 100 million doses had already expired

Adar Poonawalla, the chief executive officer of Serum Institute of India (SII), said on Thursday that the company stopped manufacturing Covishield vaccines starting December 2021, according to a report in The Economic Times. He added that of the total stock available at that time approximately 100 million doses had already expired. 

Speaking to reporters on the sidelines of the Developing Countries Vaccine Manufacturers Network (DCVMN) annual general meeting, he said that there is little demand for booster vaccines due to both- the overall lack of energy among people and their fatigue from the pandemic.

While talking about Covishield and Covovax vaccines,